Lara Jehi, MD

1. Associate Director, Clinical Research Unit- Cleveland Clinic (2012- ongoing)
2. Quality Improvement Officer, Epilepsy, Cleveland Clinic (2008-2014)
3. Neurosciences Sub-Chair, Research Programs Committee, Cleveland Clinic
4. vice-chair, Institutional Review Board, Cleveland Clinic
5. Member, Diagnostic Commission of the International League Against Epilepsy
6. Chair, Surgical Therapies Commission of the International League Against Epilepsy
7. Contributing Editor, Epilepsy Currents
8. Associate clinical editor, Epilepsy Currents
9. Associate Editor, Epilepsia Open
10. Editorial Board member, Epilepsia 
11. Ad-hoc reviewer, Acute Neuronal Injury Study Section NIH
12. Ad-hoc reviewer, Fogarty Awards Study Section, NIH
13. Ad-hoc reviewer, Foundation Françoise pour la Recherche
14. Ad-hoc reviewer, Swiss National Science Foundation
15. Chair, Annual Course Committee, American Epilepsy Society
16. Chair, Epilepsy Special Interest Group, American Neurological Association
17. Member, Executive Committee, Clinical Translational Science Collaborative, Cleveland
18. Invited member, workshop on comparative effectiveness research and randomized clinical trials in neurosurgery, NIH.

• Clinical Epidemiology and Outcomes research
• Diplomat, American Society of Neuroimaging
• Masters in Health Care Delivery Science, Dartmouth College

• First Prize in Neuroscience Research Residents Day
• Young Investigator Award (American Epilepsy Society).
• Contemporary Clinical Highlights Plenary Session presentation Award, American Academy of Neurology
• America's Most Compassionate Doctors 2011 (Patients'Choice Award)
• Nelson Butters Award from national Academy of Neuropsychologists 2012
• Best Doctors in America

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-01-24, Dr. Jehi has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.